Cargando…

Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity

The vast majority of human tumors with p53 mutations undergo loss of the remaining wildtype p53 allele (loss-of-heterozygosity, p53LOH). p53LOH has watershed significance in promoting tumor progression. However, driving forces for p53LOH are poorly understood. Here we identify the repressive WTp53–H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isermann, Tamara, Şener, Özge Çiçek, Stender, Adrian, Klemke, Luisa, Winkler, Nadine, Neesse, Albrecht, Li, Jinyu, Wegwitz, Florian, Moll, Ute M., Schulz-Heddergott, Ramona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242083/ https://www.ncbi.nlm.nih.gov/pubmed/34188043 http://dx.doi.org/10.1038/s41467-021-24064-1

Ejemplares similares

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells
por: Klemke, Luisa, et al.
Publicado: (2021)

Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
por: Ghaleb, Amr, et al.
Publicado: (2019)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor
por: Levesque, Aime A., et al.
Publicado: (2022)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis
por: Lee, Eunmyong, et al.
Publicado: (2016)

p53 further extends its reach
por: Zirngibl, Katharina, et al.
Publicado: (2013)

p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan
por: Hsieh, L-L, et al.
Publicado: (2005)

Cells with loss-of-heterozygosity after exposure to ionizing radiation in Drosophila are culled by p53-dependent and p53-independent mechanisms
por: Brown, Jeremy, et al.
Publicado: (2020)

Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
por: Muzumdar, Mandar Deepak, et al.
Publicado: (2016)

Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells
por: Osborne, Hugh C., et al.
Publicado: (2022)

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
por: Zhou, Xinyu, et al.
Publicado: (2020)

p53 Gene Mutation and Loss of Heterozygosity of Chromosome 11 in Methylcholanthrene‐induced Mouse Sarcomas
por: Shimokado, Kiyoshi, et al.
Publicado: (1998)

Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
por: Ghaleb, Amr, et al.
Publicado: (2020)

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation
por: Hausmann, Christina, et al.
Publicado: (2015)

HSF4 regulates lens fiber cell differentiation by activating p53 and its downstream regulators
por: Gao, Meng, et al.
Publicado: (2017)

Mitochondrial death functions of p53
por: Marchenko, N D, et al.
Publicado: (2014)

TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
por: Wang, Haiwei, et al.
Publicado: (2022)

Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53
por: Lindzen, Moshit, et al.
Publicado: (2021)

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
por: van der Weyden, L, et al.
Publicado: (2013)

Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)

Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors
por: Kim, Jin Hwan, et al.
Publicado: (2014)

MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas
por: Song, Yifu, et al.
Publicado: (2019)

Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism
por: Yu, Xin, et al.
Publicado: (2014)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

Mitochondrial Dysfunction in Huntington’s Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors
por: Intihar, Taylor A., et al.
Publicado: (2019)

Cooperative interaction among BMAL1, HSF1, and p53 protects mammalian cells from UV stress
por: Kawamura, Genki, et al.
Publicado: (2018)

Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
por: Kazantseva, Marina, et al.
Publicado: (2018)

p53 β-hydroxybutyrylation attenuates p53 activity
por: Liu, Kun, et al.
Publicado: (2019)

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

OTUD5 Regulates p53 Stability by Deubiquitinating p53
por: Luo, Judong, et al.
Publicado: (2013)

The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7mg404ml19gfvd42fm0elp36q0